Rational Combinations 360° Speakers
Sharon Benzeno, PhD, MBA
VP, Business Development
Sharon Benzeno, PhD, MBA, is head of business development at Adaptive Biotechnologies. Dr Benzeno is responsible for diagnostics and therapeutics programs with Adaptive’s pharmaceutical and biotechnology partners. In addition to working on Adaptive’s improved MRD test, Dr Benzeno co-leads the clinical validation of the TCRB assay in solid tumors.
Dr Benzeno has more than 15 years of experience in cancer biology, R&D and business development. Sharon worked at AstraZeneca for seven years and co-led the oncology business unit at Capgemini Consulting. Dr Benzeno has a BA in Biochemistry from New York University, a PhD in Biomedical Sciences from New York University School of Medicine and an MBA in Finance from New York University Stern School of Business. Dr Benzeno completed her postdoctoral fellowship at the Abramson Cancer Center of the University of Pennsylvania.